secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2023-06-15T23:59:59+00:00
Accession:  0001193125-23-167905
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics shareholders elect two Class I directors, ratify KPMG
-------------------------------------------------------------------------

- Michael Powell, Ph.D. elected with 15,141,283 votes for (76.2% of votes cast).
- Linda West elected with 15,219,991 votes for (76.6% of votes cast); broker non-votes were 8,447,493.
- KPMG LLP ratified as independent auditor for 2023 with 28,291,469 votes for, 9,547 against.
- Turnout was 28,312,177 shares, representing 65.98% of outstanding common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312523167905/0001193125-23-167905-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312523167905/d503234d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-167905

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer